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EDITORIAL COMMENTARYWhy do most patients with atrial fibrillation referred for other
cardiac surgery not receive concomitant ablation? A plea for
a more aggressive surgical approachRalph J. Damiano, Jr, MDSee related article on pages 3027-33.This is another in a series of important contributions from
Dr Ad and his group examining the efficacy of the
Cox-Maze procedure in different patient populations.1
There has been a popular prejudice among surgeons that
performing a Cox-Maze I procedure in high-risk patients
adds to morbidity and mortality without real benefit. This
belief can be traced back to the historical results with the
original cut-and-sew Cox-Maze III procedure. There is no
doubt that this was a complex, difficult operation that
required a long period of crossclamping, and few surgeons
considered adding this operation when performing other
concomitant cardiac procedures. In 2003, Prasad and
colleagues2 reported the results from St Louis with the
Cox-Maze III procedure. The average crossclamp time
was 90 minutes for a lone Maze III procedure, with the
majority of these patients undergoing operation by the
originator of this operation, Dr James Cox. In the hands
of less expert surgeons, this procedure often required even
more time. The mortality rate was 2% with a major
complication rate of 12%. With the introduction of the
ablation-assisted Maze IV procedure in 2004, there has
been a dramatic decrease in both the difficulty of the
operation and the time required to complete the full lesion
set.3 In comparing our experience with the stand-alone
Cox-Maze IV with the Cox-Maze III procedure, we found
that the crossclamp time was nearly cut in half, with a
significant decrease in the major complication rate from
10% to 1%.4 By using ablation devices to simplify the
procedure, this operation can now be widely applied to a
broader spectrum of patients with excellent results.
However, few reports have looked at the safety and efficacy
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3034 The Journal of Thoracic and Cardiovascular Surexcellent report examining their single-center results in
370 patients, Dr Ad and colleagues found no significant
differences in morbidity or mortality among the low-risk,
intermediate-risk, and high-risk patients.1 Moreover, the
procedure had similar efficacy in terms of restoration of
sinus rhythm in all of the groups.
These important data hopefully will lead to surgeons
having a more aggressive attitude to performing Maze
procedures in patients referred for other cardiac surgery.
There is overwhelming evidence that surgeons are still
reluctant to perform concomitant surgical ablation. In
studies examining the Society of Thoracic Surgeons
database, only approximately 20% to 39% of patients
with atrial fibrillation have surgical ablation at the time of
surgery.5 Although this may have been appropriate with
the historical Cox-Maze III procedure, it ignores the
advances that have occurred with the introduction of both
ablation devices and less-invasive approaches. It is time
for surgeons to reassess their preconceptions and be more
open to performing ablation for atrial fibrillation at the
time of concomitant cardiac surgery. As surgeons, we
have the unique opportunity to restore sinus rhythm
and improve the quality of life in these patients. The
Cox-Maze procedure remains the single most efficacious
intervention for atrial fibrillation. This report and others
have provided evidence that both low-risk and high-risk
patients benefit in a similar fashion.1 Hopefully, surgical
practice will begin to reflect these advances, and more
patients will be thought to be candidates for this important
therapeutic intervention.
There are 2 caveats that need to be emphasized regarding
this recommendation. First, these results are from a single
center, in which a very experienced surgeon performed
the majority of the procedures. Whether similar results
can be obtained at less-experienced centers remains to be
established. The superb outcomes in this report emphasize
the importance of both surgeon experience and defining
late outcomes.1 This is an operation in which success or
failure is defined as freedom from atrial fibrillation at 12
months. To obtain this information, a center needs to
make a significant investment and commitment to obtain
adequate follow-up. This requires a longitudinal database
and a dedicated team.
The second point of emphasis is that these results were
obtained with a full Cox-Maze lesion set. Unfortunately,
the majority of patients receiving surgical ablation for atrialgery c December 2014
Damiano Editorial Commentaryfibrillation receive a more limited ablation, either a left
atrial lesion set alone or a pulmonary vein isolation.
In concomitant patients, these procedures have been
significantly less efficacious in our experience.6 Surgeons
should be careful in extrapolating these excellent results
to patients who do not receive a full Cox-Maze lesion
pattern.
This excellent case series adds further information
supporting the safety and efficacy of the Cox-Maze
procedure in both low- and high-risk patients who are
referred for concomitant surgery.1 It is time for the surgical
community to translate these results into their clinical
practice and offer the Cox-Maze procedure to most patients
with atrial fibrillation who are referred for concomitant
cardiac surgery.The Journal of Thoracic and CarReferences
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